|
JCFLOW Unveils Bold New 15mm Silicone Printed Beads Collection for DIY Enthusiasts Building on its recent product expansion, JCFLOW today officially launched a dynamic line of 15mm silicone printed beads, designed to inspire creativity for DIY crafters and small business artisans alike. Known for its high-quality silicone beads, JCFLOW continues to set … Continue reading
|
Neurofibromatosis Type 2 Pipeline Leading Neurofibromatosis Type 2 Companies include Recursion Pharmaceuticals, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics, AstraZeneca, Fosun Pharmaceutical, NFlection Therapeutics, and several other innovators. The global Neurofibromatosis Type 2 (NF2) therapeutic pipeline is witnessing steady expansion, driven … Continue reading
|
|
DelveInsight’s, “Chronic Myeloid Leukaemia Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the Chronic Myeloid Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading
|
DelveInsight’s “Tendonitis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and … Continue reading
|
|
DelveInsight’s “Bipolar Disorder Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
|
DelveInsight’s, “Pre-Eclampsia Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the Pre-Eclampsia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pre-Eclampsia Pipeline Therapeutics … Continue reading
|
|
Nipocalimab Market Nipocalimab Overview in approved indications like Myasthenia gravis; as well as potential indications like Fetal erythroblastosis, Neonatal alloimmune thrombocytopenia, Sjogren’s syndrome, Systemic lupus erythematosus and others. The Nipocalimab market is entering a pivotal growth phase, driven by recent … Continue reading
|
Myelofibrosis Market Expected to Surpass USD 5.3 Billion by 2034, estimates DelveInsight Myelofibrosis Market The Myelofibrosis market across the seven major markets is projected to witness substantial expansion, growing from nearly USD 2,602 million in 2025 to about USD 5,638 million by 2034, registering a CAGR of around 9% over the forecast … Continue reading
|
|
Global Urinalysis Market Forecast to Surpass USD 9 Billion by 2032, estimates DelveInsight Urinalysis Market Urinalysis companies include F. Hoffmann-La Roche Ltd., Beckman Coulter, Siemens Healthcare, Sysmex Corporation, Abbott, Carolina Liquid Chemistries, Medline Industries, Olive Diagnostics, ACON Laboratories, Arkray Inc., and Mindray Medical International, among others The global urinalysis market is poised for … Continue reading
|
Graft Versus Host Disease Market GvHD companies include Medac, MaaT Pharma, ElsaLys Biotech (Mediolanum Farmaceutici Spa), Syndax Pharmaceuticals, Kadmon Corporation, AstraZeneca, Biogen, Amgen, Pfizer, AltruBio, CSL Behring, Incyte Corporation, Takeda, OncoImmune, Merck (MSD), Regimmune Corporation, Jazz Pharmaceuticals, Millennium Pharmaceuticals, Takeda … Continue reading
|
